Peptide index (A–Z)

Advanced bone anabolic

Myostatin inhibitor

Hypoxic pain and healing

Metabolic immune support

Fat loss, metabolic enhancement

Neuropathic pain specialist

Botox-like peptide

Immune activating complex

FDA-approved synthetic peptide direct thrombin inhibitor used for anticoagulation during PCI, including in HIT patients.

Healing & recovery, gut health

First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).

Combination therapy

FDA-approved bone resorption inhibitor

Neuroprotection, recovery

Growth hormone, muscle mass, fat loss

Structural bone and joint support

Brain bioregulator

Neuropeptide complex

Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders

Hormone precursor support

Potent cognitive enhancer

Delta sleep-inducing peptide

Weekly GLP-1 (Trulicity)

Longevity, telomere support

Anti-aging performance combo

FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.

NCAM mimetic

HGH fragment for fat loss

Wound healing, skin regeneration

Appetite and healing support

Fourth generation GHRP

Trending injectable research blend of GHK-Cu, BPC-157 and TB-500, marketed for skin rejuvenation and tissue recovery. Not FDA-approved; sold as a research chemical.

Sleep quality amino peptide

GnRH for fertility

Antiviral immune booster

Testosterone production support

Cell renewal peptide

Potent GH releaser

Mitochondrial protection, longevity

Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.

Russian immune peptide

The foundational peptide hormone for glycemic management in type 1 and type 2 diabetes mellitus.

GH secretagogue, anti-aging

Reproductive hormone regulator

Anti-inflammatory immune peptide

FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome

Gut permeability regulator

Satiety hormone

FDA-approved GLP-1 for weight loss

Antimicrobial defense peptide

Anti-aging skincare

Advanced collagen booster

Tanning, libido

Enhanced melatonin delivery

NMDA antagonist

Oral GH secretagogue

Mitochondrial optimization

Triple modified Semax

PEGylated CNP analog for achondroplasia. FDA approved February 27, 2026.

Neurogenesis, depression

FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988

Oral GLP-1

Digestive system bioregulator

Bonding and relaxation hormone

Neurogenic peptide

Collagen booster

Multi-receptor somatostatin analog (Signifor/Signifor LAR) FDA-approved for Cushing's disease and acromegaly.

Natural pain modulator

PEGylated recombinant arginase enzyme for Arginase 1 Deficiency. FDA approved February 23, 2026.

Joint and bladder support

Pineal gland bioregulator

Amylin analog for diabetes

Prostate and male hormone support

Sexual function peptide

Investigational triple agonist (GIP/GLP-1/glucagon). TRIUMPH-1 Phase 3 (May 2026): 28.3% body weight loss at 80 weeks. FDA submission anticipated Q3–Q4 2026.

Adaptogenic peptide

Anxiety reduction, focus

Extended release Selank

Weight loss, blood sugar control

Cognitive enhancement, focus, memory

Evening cognitive calming

Extended release Semax

GHRH for natural GH release

Enhanced Argireline

Spleen-derived immune peptide

Mitochondrial optimization

Collagen synthesis peptide

Tissue repair, flexibility, inflammation

TB-500 fragment

FDA-approved bone builder

GHRH for visceral fat

Thymus restoration peptide

Immune system support

Comprehensive tissue pain relief

Thyroid function support

Dual GIP/GLP-1 agonist for weight loss

Mitochondrial health compound

Simple immune dipeptide

Thymus bioregulator complex

Myostatin inhibitor